Innate Pharma S.A. logo IPHA - Innate Pharma S.A.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 4
HOLD 2
SELL 0
STRONG
SELL
0
| PRICE TARGET: $6.67 DETAILS
HIGH: $9.00
LOW: $4.00
MEDIAN: $7.00
CONSENSUS: $6.67
UPSIDE: 256.68%
AlphaQuality

AlphaQuality

Quantitative six-pillar business-quality grade

Stable Earnings Power

AlphaQuality — archetype-weighted quantitative grade

F 4.6 / 100 pillar composite

Composite Grade

Composite of six pillars weighted for stable earnings power businesses. Purely quantitative — the six pillars score only reported financials, no analyst input.

⚠ 5 of the last 5 fiscal years showed negative net income — AlphaQuality will not grade above F for persistent unprofitability in a stable earnings power business.

Grade overrides the 4.6 pillar composite because hard gates always win. Use the pillar breakdown below to see where the underlying numbers sit.

Profitability

Weight: 20%
F 0.0
  • 5yr Avg ROIC -921.5% 0/100
  • Operating Margin Trend -335.32 pp/yr 0/100
Contributes 0.0 pts toward composite.

Capital Efficiency

Weight: 15%
F 9.1
  • 5yr Avg ROE -182.8% 0/100
  • 5yr Share-Count CAGR 2.5% 26/100
Contributes 1.4 pts toward composite.

Growth Quality

Weight: 15%
F 6.2
  • 5yr Revenue CAGR -47.5% 0/100
  • Revenue-Growth Years (5) 1/5 20/100
Contributes 0.9 pts toward composite.

Cash Generation

Weight: 15%
F 0.0
  • 5yr FCF Margin -381.3% 0/100
  • 5yr FCF/NI Conversion 0.00x 0/100
Contributes 0.0 pts toward composite.

Balance Sheet

Weight: 20%
F 0.0
  • Net Debt / EBITDA 10.00x 0/100
  • Interest Coverage (EBIT/Int) -110.77x 0/100
  • Altman Z-Score -9.66 0/100
Contributes 0.0 pts toward composite.

Stability

Weight: 15%
F 15.2
  • Negative-Revenue Years (5) 4/5 20/100
  • Piotroski F-Score 1 11/100
Contributes 2.3 pts toward composite.

Guru Flow

Curated superinvestor sentiment — not part of the AlphaQuality grade.
Not Followed

Not held by any curated guru.

How this is calculated

AlphaQuality grades six pillars from 0-100 and weights each by archetype:

  • Profitability (20%) — 5yr Avg ROIC, Operating Margin Trend
  • Capital Efficiency (15%) — 5yr Avg ROE, 5yr Share-Count CAGR
  • Growth Quality (15%) — 5yr Revenue CAGR, Revenue-Growth Years (5)
  • Cash Generation (15%) — 5yr FCF Margin, 5yr FCF/NI Conversion
  • Balance Sheet (20%) — Net Debt / EBITDA, Interest Coverage (EBIT/Int), Altman Z-Score
  • Stability (15%) — Negative-Revenue Years (5), Piotroski F-Score

The six pillars read only reported financial-statement fields — no analyst targets or consensus ratings. The archetype that picks which pillar formulas apply is not fully price-free, though: it can route a company to the distressed/ungradable archetype based on price vs. its 52-week high, and beta affects one classification check. A minimum of 5 fiscal years of audited statements is required. Insurers and banks are graded on their own methodology — insurers on loss ratio, its trend and stability, and premiums-to-surplus; banks on the efficiency ratio, its trend and stability, and equity-to-assets — rather than on industrial margin/ROIC signals. Distressed, highly leveraged infrastructure, asset-manager, and other financial businesses are declared ungradable rather than forced into a numeric score.